Brief: Hera Med Says Tim Chapman Appointed As Chair
May 10 (Reuters) - Hera Med Ltd 1I4.F :
* ANOUSHKA GUNGADIN, RECENTLY APPOINTED AS CEO JOINS BOARD
AS
MANAGING DIRECTOR
* TIM CHAPMAN APPOINTED AS CHAIR OF BOARD
* TIM CHAPMAN REPLACING RON WEINBERGER AS CHAIR
* BENEFITS OF REDUCTION IN OPERATING COST BASE EXPECTED TO
BE
REALISED FROM SECOND HALF OF 2024
Further company coverage: 1I4.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Heramed
See all newsAustralia's HeraMED on track for best day in over two months
Brief: HeraMED Says Lee Health Approves Expansion Of HeraMED Maternity Program
Brief: HeraMED To Raise A$3.2 Mln At A$0.04 Per Share
Brief: Heramed Seeks Trading Halt Pending Capital Raise Announcement
Brief: Heramed Partners With Philips For US Maternity Solution